Cue Biopharma, Inc. · DUS:1UC0

Cue Biopharma, Inc. insider trades

Cue Biopharma, Inc.'s insiders made 0 buys and 15 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Ray Sumita
Officer: Chief Legal Compliance Officer, Other: Corporate Secretary
Sale1,844USD 28.05US$51,724Oct 12, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale10,000USD 27.50US$275KOct 12, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale1,087USD 28.05US$30,490Oct 12, 2026
Meluzio Michael Vincent
Officer: VP, Prin. Accounting Officer
Sale1,144USD 28.05US$32,089Oct 12, 2026
Ray Sumita
Officer: Chief Legal Compliance Officer, Other: Corporate Secretary
Sale2,383USD 29.37US$69,989Aug 13, 2026
Ray Sumita
Officer: Chief Legal Compliance Officer, Other: Corporate Secretary
Sale6,442USD 30.35US$196KAug 13, 2026
Ray Sumita
Officer: Chief Legal Compliance Officer, Other: Corporate Secretary
Sale4USD 31.13US$125Aug 13, 2026
Meluzio Michael Vincent
Officer: VP, Prin. Accounting Officer
Sale1,519USD 29.37US$44,613Aug 13, 2026
Meluzio Michael Vincent
Officer: VP, Prin. Accounting Officer
Sale4,106USD 30.35US$125KAug 13, 2026
Meluzio Michael Vincent
Officer: VP, Prin. Accounting Officer
Sale3USD 31.13US$93Aug 13, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale5,423USD 27.19US$147KAug 13, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale2,375USD 28.11US$66,761Aug 13, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale10,460USD 29.48US$308KAug 13, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale34,225USD 26.99US$924KAug 12, 2026
Lin Shao-Lee
Director, Officer: Chief Executive Officer
Sale5,775USD 27.75US$160KAug 12, 2026

Cue Biopharma, Inc. shareholders